Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should cancer patients receive thromboprophylaxis to prevent catheter-related upper limb deep vein thrombosis?

× No keyword cloud information.

18 in total

Review 1. Prevention of venous thromboembolism.

Authors: W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal: Chest Date: 2001-01 Impact factor: 9.410

2. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.

Authors: A N Nicolaides; H K Breddin; J Fareed; S Goldhaber; S Haas; R Hull; E Kalodiki; K Myers; M Samama; A Sasahara
Journal: Int Angiol Date: 2001-03 Impact factor: 2.789

3. Thromboprophylaxis for catheter-related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials.

Authors: M Carrier; J Tay; D Fergusson; P S Wells
Journal: J Thromb Haemost Date: 2007-12 Impact factor: 5.824

Review 4. Cancer and venous thromboembolism.

Authors: Paolo Prandoni; Anna Falanga; Andrea Piccioli
Journal: Lancet Oncol Date: 2005-06 Impact factor: 41.316

5. Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters.

Authors: Diana Gaitini; Nira Beck-Razi; Nissim Haim; Benjamin Brenner
Journal: J Ultrasound Med Date: 2006-10 Impact factor: 2.153

6. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Authors: Melina Verso; Giancarlo Agnelli; Sergio Bertoglio; Franco C Di Somma; Francesco Paoletti; Walter Ageno; Mario Bazzan; Pasquale Parise; Roberto Quintavalla; Emanuele Naglieri; Armando Santoro; Davide Imberti; Mariella Sorarù; Stefano Mosca
Journal: J Clin Oncol Date: 2005-03-14 Impact factor: 44.544

7. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

Authors: Stephen Couban; Michael Goodyear; Margot Burnell; Sean Dolan; Parveen Wasi; David Barnes; Darlene Macleod; Erica Burton; Pantelis Andreou; David R Anderson
Journal: J Clin Oncol Date: 2005-03-14 Impact factor: 44.544

Review 8. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

Authors: Melina Verso; Giancarlo Agnelli
Journal: J Clin Oncol Date: 2003-10-01 Impact factor: 44.544

9. Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis.

Authors: F Dentali; M Gianni; G Agnelli; W Ageno
Journal: J Thromb Haemost Date: 2007-11-06 Impact factor: 5.824

10. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.

Authors: T M H Niers; M Di Nisio; C P W Klerk; H J Baarslag; H R Büller; B J Biemond
Journal: J Thromb Haemost Date: 2007-09 Impact factor: 5.824

1 in total

1. Risk and prophylaxis of catheter-related venous thromboembolism after cardiac surgery: where is the evidence?

Authors: Davide Imberti
Journal: Intern Emerg Med Date: 2008-09-16 Impact factor: 3.397

1 in total